Equity
€90,551 ▲ 117%
MéDICLEM paid out €833 in dividends. That is 2% of the 2025 profit.
MéDICLEM
Lifetime
2 annual accounts with figures on one time axispeak €68,656 (2025)
€68,656▲ 35.1%
peak €49,664 (2025)
€49,664▲ 25.5%
peak €90,551 (2025)
€90,551▲ 117%
€5,955▼ 66.5%
Board1 name since 2023
1 directorde la CROIX Clémence Anne Frédérique
Documentsfilings and deeds
01-07-202630 days before the deadline
2025micro format
Gross margin from €50,833 to €68,656Result from €39,579 to €49,664Dividend €833Equity from €41,720 to €90,551Debts from €17,778 to €5,955Investments €10,000
Key points
from the 2025 annual accountsInvestments
€10,000 1.9 × depreciation
Green is investment, beige is depreciation.
Liquidity
15.06 was 3.22 in 2024
Short-term debts fell from €17,778 to €5,955.
Checked score
91
Excellent
Financially stronger than 90% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%
About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
01-2025: 2.5%
02-2025: 2.5%● unchanged vs 01-2025
03-2025: 2.6%▲ +0.1 percentage points vs 02-2025
04-2025: 3.0%▲ +0.4 percentage points vs 03-2025
05-2025: 3.2%▲ +0.2 percentage points vs 04-2025
06-2025: 3.5%▲ +0.3 percentage points vs 05-2025highest value
07-2025: 3.5%● unchanged vs 06-2025highest value
08-2025: 0.4%▼ -3.1 percentage points vs 07-2025
09-2025: 0.4%● unchanged vs 08-2025
10-2025: 0.4%● unchanged vs 09-2025
11-2025: 0.4%● unchanged vs 10-2025
12-2025: 0.4%● unchanged vs 11-2025
01-2026: 0.5%▲ +0.1 percentage points vs 12-2025
02-2026: 0.5%● unchanged vs 01-2026
03-2026: 0.6%▲ +0.1 percentage points vs 02-2026
04-2026: 0.6%● unchanged vs 03-2026
05-2026: 0.6%● unchanged vs 04-2026
06-2026: 0.6%● unchanged vs 05-2026
07-2026: 0.7%▲ +0.1 percentage points vs 06-2026
08-2026: 0.3%▼ -0.4 percentage points vs 07-2026
09-2026: 0.3%● unchanged vs 08-2026
10-2026: 0.3%● unchanged vs 09-2026lowest value
11-2026: 0.3%● unchanged vs 10-2026lowest value
Financial strengthStrong
Score breakdown
raises risk
Founded in 2023
No main activity registered
lowers risk
Liquidity: current ratio 15.06, cash €86,123
Size: total assets €96,506
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 95% on liquidity, 90% on profitability and 93% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 39,278 companies had the same profile as MéDICLEM has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
The bankruptcy probability of MéDICLEM itself is lower: 0.3% within 12 months. It rests on far more data about MéDICLEM than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for MéDICLEM. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €8,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity is ample, with a current ratio of 15.06 (3.22 in 2024), above the usual 1.5. Short-term debt is 6.2% and cash 89.2% of total assets. 6.2% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 01-07-2026, 30 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
30 days early
2024
23 days early
← before the deadline
after the deadline →
tick = median of all Belgian filings
The company filed its last 2 accounts on average 27 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsWhere today falls in the filing period
08-11-2026 today31-12-2026 year end31-07-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1004016712
Incorporation
Founder: de la CROIX Clémence Anne Frédérique (comparante) · 100 shares · Appointment: de la CROIX Clémence Anne Frédérique (director) · published on 02-01-2024 · Gazette deed
First establishment
Rue Joséphine Rauscent 138, Wavre
Official details
Source: KBO- Status
- Active since 28-12-2023Normal situation
- Activity
- “Interdit toute exploitation commerciale de la médecine” (deed in French)From the articles, 9 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.356.189.9801300 Wavre, since 28-12-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 16-01-2024
Annual accounts 2025
- ≈ €210,000estimated
- €96,506▲ 62.2%
- Filing
- Filed on 01-07-2026, 30 days before the end of the filing period
Insights on MéDICLEM
MéDICLEM has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €90,551 and a net result of €49,664.
The computed 12-month bankruptcy probability is 0.3% (very low).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MéDICLEM
- What is the company number of MéDICLEM?
- The company number of MéDICLEM is 1004.016.712. The VAT number is the same number with BE in front: BE 1004.016.712.
- Where is MéDICLEM based?
- The registered office is at Leopoldstadplein 8, 1040 Etterbeek.Company details
- What is the legal form of MéDICLEM?
- MéDICLEM is a private limited company (BV).
- When was MéDICLEM founded?
- MéDICLEM was founded on 28-12-2023.
- Is MéDICLEM still active?
- Yes, MéDICLEM is an active enterprise in the KBO register.
- What is the turnover of MéDICLEM?
- The turnover in financial year 2025 is ≈ €210,000. This figure is estimated from the gross margin of €68,656 and 2,663 comparable companies of the same size. It probably lies between €140,000 and €360,000. It is a rough estimate.Financials
- Is MéDICLEM profitable?
- In financial year 2025, MéDICLEM made a profit of €49,664.
- Where can I find the annual accounts of MéDICLEM?
- MéDICLEM filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MéDICLEM due?
- MéDICLEM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.